Identification of Biomarkers, New Treatments, and Vaccines for COVID-19

The novel coronavirus 2019 (COVID-19) has caused a severe global pandemic, affecting nearly every country and territory. It has profound virulence and infection rates, particularly affecting elderly individuals and those with co-morbid diseases. A rapid worldwide mobilization effort is underway to identify effective treatments and develop vaccines to bring the virus under control. This book will provide valuable insights into the pandemic by discussing new treatment approaches, vaccine development, mental health aspects, and survey studies. It is a resource for researchers, physicians, drug companies, healthcare services, and workers.

Format: Hardback
Length: 234 pages
Publication date: 20 July 2021
Publisher: Springer Nature Switzerland AG

The novel coronavirus 2019 (COVID-19) has caused a severe global pandemic in just one year, affecting nearly every country and territory in the world. The virus's virulence and infection rate are profound, necessitating extreme social distancing measures to prevent overwhelming healthcare services and hospitals. COVID-19 has the greatest impact on elderly individuals and those with co-morbid diseases such as diabetes and obesity. With cases and death rates remaining high, there are justified fears that the virus will persist for several months or years. To address this, a rapid and unprecedented worldwide mobilization effort has begun to identify effective treatments and develop vaccines. As these efforts begin to deploy and administer globally, many hope that the virus will be brought under control, and lives will eventually return to normal.

This new volume aims to enhance readers' understanding of the ongoing COVID-19 pandemic through a series of chapters that address these concerns. Leading experts will discuss new treatment approaches, vaccine development, mental health aspects of the pandemic, and convey the results of survey studies. The book will be an excellent resource for researchers studying virology, metabolic diseases, respiratory disorders, clinical scientists, physicians, drug companies, and healthcare services and workers.

The impact of COVID-19 has been far-reaching, affecting not only public health but also the global economy, social interactions, and mental well-being. The virus has highlighted the importance of robust healthcare systems, rapid response mechanisms, and global cooperation in combating infectious diseases. It has also raised concerns about the vulnerability of older populations, the impact of climate change on public health, and the need for sustainable healthcare practices.

As the world continues to grapple with the pandemic, it is essential to stay informed and take necessary precautions to protect ourselves and others. This includes practicing good hygiene, wearing masks, practicing social distancing, and getting vaccinated when eligible. It is also important to support healthcare workers and organizations that are working tirelessly to combat the virus and provide care to those affected.

In conclusion, the novel coronavirus 2019 (COVID-19) has caused a severe global pandemic that has impacted the lives of millions of people worldwide. The virus's virulence and infection rate are profound, necessitating extreme social distancing measures to prevent overwhelming healthcare services and hospitals. COVID-19 has the greatest impact on elderly individuals and those with co-morbid diseases, highlighting the importance of robust healthcare systems and global cooperation in combating infectious diseases. As the world continues to grapple with the pandemic, it is essential to stay informed, take necessary precautions, and support healthcare workers and organizations to combat the virus and restore normalcy.

Weight: 663g
Dimension: 254 x 178 (mm)
ISBN-13: 9783030716967
Edition number: 1st ed. 2021